UK Vaccine Taskforce’s Clive Dix: IP Is A Distraction, We Need To Vaccinate The World As Fast As Possible
UK Should Make Decision On Dose Sharing Now
Executive Summary
Clive Dix, who recently stepped down as chair of the UK Vaccine Taskforce, shares with Pink Sheet his views on its success, why AstraZeneca has been unfairly criticized, how the UK should now share its doses with other countries, and the exciting future of vaccine technology.
You may also be interested in...
Your Annual COVID-19 Vaccine Booster Could Be A Pill Or A Spray
A COVID-19 vaccine in a pill being developed by Vaxart and a nasal spray from Altimmune could offer convenience and maybe even superior immunity compared to injections.
Sanofi Partnership On Oral IL-17 Could Be Turning Point For C4XD
The UK drug discovery specialist has made slow progress until now, but the Sanofi deal could yield a challenger in the competitive psoriasis field.
Precision Keeps Faith In Duchenne Gene-Editing After Lilly’s Exit
The company has pledged to continue developing its Duchenne in vivo gene editing therapy without Lilly, but will remain focused on its lead program in hepatitis B.